FINWIRES · TerminalLIVE
FINWIRES

RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570

By

Vertex Pharmaceuticals (VRTX) has an average rating of overweight and mean price target of $5

Price: $485.78, Change: $-12.65, Percent Change: -2.54%

Related Articles